
Rewriting the Narrative on Nuclear Weapons
To build political will for meaningful policy change on nuclear risk reduction and disarmament, NTI is changing the narrative on nuclear weapons.
To build political will for meaningful policy change on nuclear risk reduction and disarmament, NTI is changing the narrative on nuclear weapons.
"Rewriting the Narrative on Nuclear Weapons: A research-based guide to building a safer future" provides those seeking to reduce nuclear risks and eventually eliminate nuclear weapons an evidence-based narrative framework to connect with a supermajority of Americans to shift policy, practices, and beliefs by focusing on shared values.
For those seeking to reduce nuclear risks and eventually eliminate nuclear weapons, Rewriting the Narrative on Nuclear Weapons is a practical, research-based guide designed to reverse the dominant narrative that nuclear weapons keep us safe.
NTI | bio has responded to the U.S. government request for information (RFI) related to the Artificial Intelligence (AI) Action Plan outlined by President Donald Trump’s January 2025 Executive Order, providing input on the highest priority actions to maintain and extend U.S. global leadership on AI.
NTI | bio hosts this competition to provide a platform for the next generation of global leaders in biosecurity to develop original concepts and share them with the wider biosecurity community.
Since the emergence of the term in the late 20th century, “biosecurity” has had a wide variety of meanings. While biosecurity is fundamental to the work of NTI | bio, we have not explicitly laid out our definition of biosecurity — until now.
A pandemic is not a once in a century event, and the international community must prepare now for the next one. It is essential the international community strike a balance between fostering and supporting beneficial AIxBio innovation while guarding against accidental or deliberate misuse of these tools.
Collection of Iranian missile tests including the date, time, missile name, launch agency, facility name, and test outcome. (CNS)